Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Study - CLL13 - GVe - Obinutuzumab (100/900/1000) / Venetoclax 20, Chronic Lymphocytic Leukemia, Cycle 1

Protocol-ID: 1144 V1.1 (Mini), STUDY-CLL13-GVe-OBIN(100/900/1000)/VNTC20, CLL, C1

Indication(s)

  • Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 23.07.2020